Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal

Clinical trial NCT06962007 · RECRUITING

Trial details

NCT number: NCT06962007
Sponsor: Wonkwang University Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Neuromuscular Blockade Reversal Agent Perioperative Complications Anesthesia, General Sugammadex Monitoring, Intraoperative Masseter Muscle Spasm

Start date: 2025-07-01
Primary completion: 2026-09-20
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.